- What is the UKRI funding pause?
- Reopening timeline: council by council
- Building a submission calendar around funder pauses
- Answer-first Q&A
- Implications for research offices
- Outlook for the rest of 2026
The UKRI funding pause that unsettled applicant-led research funding in early 2026 is now, council by council, being lifted. UK Research and Innovation suspended several open competitions across the Medical Research Council (MRC) and Biotechnology and Biological Sciences Research Council (BBSRC) while it re-engineered its application infrastructure, and separately paused a set of Engineering and Physical Sciences Research Council (EPSRC) programme grant areas as part of a wider budget reshape. For research offices, the practical question is no longer “what happened” but “when do I need my next round of applications ready” — and that requires a working calendar, not just a news alert.
What is the UKRI funding pause?
UKRI announced in January and February 2026 that it was pausing applications to several MRC and BBSRC applicant-led schemes while it moved those councils to an “always open” submission model. The stated rationale, published on UKRI’s own Pauses to funding opportunities page, is that fixed external deadlines create sharp peaks in application volume and reviewer demand; removing them is meant to smooth both.
The pause sits inside a much larger restructuring. In late 2025, the Department for Science, Innovation and Technology (DSIT) and UKRI set out how £38.6 billion of public R&D funding over four years will be allocated across three new “buckets”: curiosity-driven research, strategic government and societal priorities, and support for innovative companies — each intended to represent roughly 50%, 25% and 25% of spend respectively, according to UKRI chief executive Professor Sir Ian Chapman. Overall UKRI funding is set to rise toward £10 billion a year by 2030, even as individual scheme timelines shift.
A separate, unrelated cost pressure hit the Science and Technology Facilities Council (STFC), which must deliver £162 million in cost reductions by 2029–30 because of inflation and unfavourable currency exchange rates on international facility costs — prompting project leaders to model reductions of 20%, 40% and 60% to grant lines. UKRI has stated this is a cost-management issue, not a change to the funding model that paused MRC and BBSRC calls.
Reopening timeline: council by council
As of UKRI’s most recent update (15 June 2026), most paused schemes have already reopened. The table below consolidates confirmed dates for planning purposes; always cross-check the live UKRI Funding Finder before committing internal deadlines, since UKRI funding service records supersede any secondary summary.
| Council | Scheme | Status |
|---|---|---|
| MRC | Applicant-led research grants | Reopened 7 April 2026 |
| MRC | New investigator research grants | Reopened 7 April 2026 |
| MRC | Partnership grants | Reopened 7 April 2026 |
| MRC | Experimental medicine opportunities | Reopened 30 April 2026 |
| MRC | Proof of Concept (formerly Developmental Pathway Funding Scheme) | Reopening July 2026 |
| MRC | Impact Acceleration Awards (formerly the Gap Fund) | Reopening July 2026 |
| MRC | Fellowships, studentships, Centres of Research Excellence | Never paused |
| BBSRC | New investigator award (applicant-led mode) | Reopened |
| BBSRC | Standard research grant (applicant-led mode) | Reopened |
| EPSRC | Programme grants — energy/decarbonisation, manufacturing/circular economy, quantum technologies | Paused at least 12 months from December 2025; no reopening date confirmed |
All other UKRI funding opportunities — across STFC, NERC, ESRC, AHRC, Innovate UK and Research England — continued without interruption throughout the pause. UKRI has consistently described the MRC/BBSRC pauses as short and administrative rather than budgetary.
Building a submission calendar around funder pauses
Because the “always open” model removes fixed external deadlines from some schemes while other councils retain calls with hard cut-offs, research offices increasingly need internal, rolling calendars rather than a single annual grants diary. A practical build process:
- Audit exposure quarterly. List every live application in the pipeline against the specific UKRI funding opportunity ID, not just the council name — pauses have applied to named schemes, not entire councils.
- Track the Funding Finder, not secondary news. UKRI funding opportunities pages are updated directly when a scheme reopens; sector commentary (LinkedIn, Reddit, trade press) often lags by days or weeks.
- Buffer internal deadlines. Build a two- to four-week internal review buffer ahead of any reopened scheme’s first post-pause round, since demand typically spikes when a paused call reopens.
- Flag early-career risk separately. Vitae and Times Higher Education have both warned that even short pauses disproportionately affect early- and mid-career researchers on fixed-term contracts; research offices should track affected individuals, not just projects.
- Distinguish administrative pauses from budget cuts. The MRC/BBSRC “always open” pause and the STFC cost-reduction exercise are separate processes with different planning implications — do not conflate a scheme reopening with a budget line being restored.
Answer-first Q&A
What is the UKRI funding pause?
The UKRI funding pause refers to UKRI’s temporary suspension of several applicant-led funding opportunities within the MRC and BBSRC in early 2026, while those councils moved to an “always open” application system. It affected named schemes only, not entire council budgets, and most paused calls have since reopened.
When will paused UKRI funding calls reopen?
Most MRC applicant-led, new investigator and partnership grants reopened on 7 April 2026, with experimental medicine opportunities following on 30 April 2026. MRC Proof of Concept and Impact Acceleration Awards are scheduled for July 2026. BBSRC’s new investigator and standard research grants have also reopened.
Which UKRI councils were affected by the funding pause?
The pause primarily affected the Medical Research Council (MRC) and Biotechnology and Biological Sciences Research Council (BBSRC). Separately, EPSRC paused specific programme grant areas — energy, manufacturing and quantum technologies — for at least 12 months from December 2025. Other councils continued normally.
How do I check current UKRI funding opportunities?
Use the official UKRI Funding Finder at ukri.org/opportunity/, which lists every open, upcoming and recently reopened UKRI funding call directly from the UKRI funding service. This is the authoritative source; treat funder pause news coverage as a prompt to check the Finder, not a substitute for it.
Implications for research offices
The 2026 episode is a useful stress test of institutional grants administration. Offices that tracked pauses at the individual scheme level, rather than assuming an entire council was closed, were able to keep pipeline applicants moving toward the schemes that stayed open throughout — STFC calls, NERC, ESRC, AHRC and Innovate UK activity were unaffected by the MRC/BBSRC pause. Conversely, offices that paused all outreach on “UKRI funding” as a category lost weeks of preparation time on schemes that never stopped.
The Campaign for Science and Engineering (CaSE) has separately pressed UKRI for clearer, comparable data on how the new three-bucket allocation model maps to historic research council spending, noting that the shift to “curiosity-driven”, “strategic priorities” and “innovative companies” buckets makes year-on-year comparison difficult. Research administrators building multi-year forecasts should treat pre-2026 allocation figures and post-restructure figures as not directly comparable, per UKRI’s own guidance to the House of Commons Science, Innovation and Technology Committee.
Outlook for the rest of 2026
Two threads remain open. First, EPSRC’s paused programme grant areas (energy and decarbonisation, manufacturing and the circular economy, quantum technologies) have no confirmed reopening date and are paused for a minimum of 12 months from December 2025 — institutions with pipeline work in these areas should plan for early 2027 at the earliest. Second, STFC’s £162 million cost-reduction programme runs through 2029–30 and will continue to affect grant, facility and international-collaboration budgets even as the MRC/BBSRC application pause itself is resolved. Research offices should keep these two processes on separate tracks in their planning calendars: one is an application-system change that is largely complete, the other is a multi-year budget exercise still working through its consequences.
For institutions building longer-range research administration calendars, the practical takeaway from the 2026 pause is procedural: track named schemes via the Funding Finder rather than council-wide status, separate administrative pauses from budget decisions, and maintain a rolling internal deadline buffer for any “always open” scheme rather than relying on a fixed annual cycle.
